Jae Sevelius, PhD
|School||UCSF School of Medicine|
|Address||550 16th. Street|
San Francisco CA 94158
|University of California, San Francisco||Postdoctoral Research Scholar||Medicine|
|University of Missouri||PhD||Clinical Psychology|
|University of Oregon||Pre-doctoral internship, APA-accredited||Counseling and Testing Center|
|University of Missouri||M.A.||Gender Studies|
|University of Florida||Bachelor of Science||Psychology|
|CAPS, UCSF||2010||Innovative Dissemination Award|
|Association of American Medical Colleges||2014||Early Career Women Faculty Professional Development (EWIMS)|
|CORO, UCSF||2015||UCSF CORO Faculty Leadership|
|Gladstone Center for AIDS Research, UCSF||2016||Early Career Research Excellence Award - Behavioral Science |
Jae Sevelius, PhD, is a licensed clinical psychologist and Associate Professor with the Center for AIDS Prevention Studies (CAPS) in the Department of Medicine at the University of California, San Francisco. Dr. Sevelius leads several research projects at the Center of Excellence for Transgender Health to promote increased access to culturally competent health care for transgender people. With funding from the National Institutes of Health and the California HIV/AIDS Research Program, Dr. Sevelius’ research is focused on leveraging data to develop culturally relevant, transgender–specific programs and interventions to promote holistic health and wellness among transgender people, with an emphasis on serving transgender women of color and those affected by HIV. Dr. Sevelius is currently conducting a pilot randomized controlled trial of ‘Sheroes’, a sexual risk reduction and empowerment intervention developed in collaboration with and for transgender women of color (R34MH102109) with funding from NIMH. She is also developing an intervention for transgender women incarcerated in the San Francisco County Jail (R34DA038541) with funding from NIDA to increase engagement in health care upon reentry into the community. Additionally, Dr. Sevelius is Co-Investigator on several transgender-focused projects, including a national demonstration project testing interventions to engage and retain HIV+ transgender women of color in care (PI: G. Rebchook), and formative research with transgender women in Brazil (PI: S. Lippman). Dr. Sevelius is also interested in exploring pre-exposure prophylaxis (PrEP) as an HIV prevention tool for transgender people, and has conducted several qualitative studies to explore barriers and facilitators to PrEP uptake among transgender women, especially those at highest risk of HIV acquisition. Maintaining a focus on community collaboration and trauma-informed intervention development, Dr. Sevelius seeks to develop and evaluate health promotion programs for transgender people that empower and draw on inherent strengths in the communities she serves.
Community-based research with transgender communities
, transgender health
, HIV/AIDS prevention and treatment among transgender people
, pre-exposure prophylaxis (PrEP) for transgender people
, treatment compliance/medication adherence
, trauma-informed care
, transgender mental health
, intervention development
, health care empowerment
, correctional settings
, substance use and treatment
, harm reduction
, diversity issues
, complimentary and alternative medicine.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.